

Publisher: Bentham Science Publishers
E-ISSN: 1875-533x|22|7|891-901
ISSN: 0929-8673
Source: Current Medicinal Chemistry, Vol.22, Iss.7, 2015-03, pp. : 891-901
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Diabetes is a metabolic disorder characterized by elevation of glucose levels in the blood that develops in humans as a result of genetic predisposition and environmental factors. Unbalanced glycemic control has been associated with the development of progressive and debilitating complications that dramatically affect the quality of life and life expectancy of people with diabetes. The purinergic system represents a widely diffused signaling pathway in mammalian cells of different tissues where it plays critical roles in both physiological and pathological conditions. Herein we review the increasing evidence supporting that the purinergic system plays an important role in the multiple facets of diabetes, including its physiopathology and complications. We also discuss the potential relevance of the purinergic pathway for diagnosis and treatment of diabetes.
Related content


P2X Receptors and Inflammation
Current Medicinal Chemistry, Vol. 22, Iss. 7, 2015-03 ,pp. :


Purine Ionotropic (P2X) Receptors
Current Pharmaceutical Design, Vol. 13, Iss. 23, 2007-08 ,pp. :


The Role of P2X Receptors in Bone Biology
Current Medicinal Chemistry, Vol. 22, Iss. 7, 2015-01 ,pp. :


P2X Receptors, Sensory Neurons and Pain
Current Medicinal Chemistry, Vol. 22, Iss. 7, 2015-03 ,pp. :


Emerging Roles of P2X Receptors in Cancer
Current Medicinal Chemistry, Vol. 22, Iss. 7, 2015-03 ,pp. :